Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lynparza granted orphan drug designation in Japan for BRCA-mutated metastatic pancreatic cancer

19 March 2020 07:00 GMT   Lynparza granted orphan drug designation in Japanfor BRCA-mutated metastatic pancreatic cancer   Designation based on the Phase III POLO trial that showed Lynparza nearly doubled the time patients lived without disease progression vs. placebo   AstraZeneca today announced that Lynparza (olaparib) has been granted orphan drug designation (ODD) in Japan for the maintenance treatment of germline BRCA-mutated (gBRCAm) curatively unresectable pancreatic cancer. Lynparza is co-developed and co-commercialised with MSD Inc., Kenilworth, N.J., US (MSD:

SBB sells a property to Alecta for SEK 460m

Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) sells the property Mimer 7 in Stockholm to Alecta for SEK 460m, corresponding to a square meter price of SEK 67,597. The property contains 6,805 square meters of premises with a rental income of SEK 14.6m and an estimated net operating income of SEK 13.7m. The closing will take place on 31 March 2020. “SBB announces the first sale of the planned SEK 11bn disposal, six weeks post the offer period for Hemfosa shares having expired. We continue to prepare the company for a BBB+ rating by continuing to focus on the ownership of community

Notice to attend the Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)

N.B. This English text is an unofficial translation of the Swedish original of the notice to attend the annual general meeting. In case of any discrepancies between the Swedish and English language versions, the Swedish version shall prevail. March 19, 2020 – The shareholders in InDex Pharmaceuticals Holding AB, reg. no. 559067-6820 (the “Company”), are hereby given notice to attend the annual general meeting at 5 p.m. on Monday 20 April 2020 at Setterwalls Advokatbyrå’s offices at Sturegatan 10 in Stockholm. Registration for the meeting commences at 4.30 p.m.NoticeShareholders wishing

Fiskars Corporation comparable EBITA unlikely to increase in 2020 due to the COVID-19 outbreak

Fiskars CorporationInsider InformationMarch 19, 2020 at 09:00 EET Fiskars Corporation comparable EBITA unlikely to increase in 2020 due to the COVID-19 outbreak Fiskars Corporation withdraws its guidance on the outlook for 2020, which was issued on February 5, 2020. Due to the corona virus outbreak, the comparable EBITA is unlikely to increase in 2020. As the situation evolves rapidly, it is too early to make reasoned estimates on the potential impact. Fiskars expects to guide the outlook for the full year 2020, once a more reliable estimate on the potential impact can be made.

Sinch AB (publ): Sinch adds conversational AI capabilities through acquisition

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH Sinch AB (publ), a global leader in cloud communications for mobile customer engagement, has entered into a definitive agreement to acquire Chatlayer BV for an Enterprise Value of EUR 6.9 million. Founded in Antwerp in early 2018, ChatLayer.ai is a cloud-based software platform that lets businesses create multi-lingual chatbots and voicebots using Artificial Intelligence (AI) and Natural Language Understanding (NLU). The platform enables intelligent two-way conversations between businesses and their customers across multiple

Vestas secures full wind volume from Danish auction round with new order for two projects

News release from Vestas Northern and Central EuropeHamburg, 19 March 2020Vestas has won a 63 MW order to supply, install and commission 16 wind turbines for two projects in central Jutland in Denmark. With this order, Vestas has secured the total 135 MW wind volume of the second technology-neutral auction in Denmark in 2019, underlining Vestas’ unparalleled ability to support customers in submitting winning auction bids.The order is placed by Eurowind Energy A/S, a leading developer and operator of sustainable energy projects and a key customer for Vestas in Denmark and Europe.

Making a difference in challenging times

As a food and beverage company, Paulig plays an important role in securing the continued supply of goods to consumers. Meanwhile, we are doing our utmost to minimize the risk of continued spread of Covid-19 in the society, by taking precautionary measures in all parts of our value chain. It is our firm belief that Paulig, together with our suppliers, customers and partners, can make a difference in these challenging times.Employees At Paulig, the health and wellbeing of our employees are always top priority. Taking precautionary measures to make sure our employees stay safe, also means

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    19 March 2020 at 08:30   Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Callardo Capital Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Kalliokoski Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20200318134659_2 __________________

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    19 March 2020 at 08:30   Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Callardo Capital Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Kalliokoski Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20200318134047_2 __________________

Elekta named a silver winner of the 2020 Edison awards

Elekta Unity MR-Linac chosen as a winner by a global panel of over 3,000 leading business executivesSTOCKHOLM, March 19, 2020 – Elekta (EKTA-B.ST) announced today that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system took the silver award for radiation treatment advancements in the medical/dental category. Among the nomination entries comprising the best products, services, and businesses in innovation for the year 2020, Unity was chosen as a winner by a panel of over 3,000 leading business executives from around the world.   “After a thorough review, the Edison

Vasakronan signs seven-year green loan agreement with NIB

Vasakronan AB and the Nordic Investment Bank (NIB) have signed an agreement for a seven-year green loan of SEK 750 million for the construction of green office properties in Stockholm.In central Sundbyberg, one of Sweden’s fastest-growing municipalities, Vasakronan is constructing the Nya Kronan property. The project encompasses a total of 47,000 square metres in two new buildings and one existing building that will be renovated. The Swedish Tax Agency will rent 42,000 square metres and is therefore the largest tenant. Since Vasakronan was founded in 2008, the company has focused on

Kesko cancels the Annual General Meeting scheduled for 30 March 2020, shall convene a new meeting at a later date

Due to developments concerning the COVID-19 coronavirus, the Board of Directors of Kesko Corporation has decided to cancel the Annual General Meeting scheduled to be held on 30 March 2020. The company shall convene a new meeting at a date to be confirmed later.The Finnish Government decided on 16 March 2020 to restrict public gatherings to a maximum of 10 people. Although Kesko’s Annual General Meeting is not deemed a public gathering, Kesko Corporation’s Board of Directors has decided, in light of the new guidelines issued by the Finnish Government, not to hold its Annual General Meeting

Kvaerner maintains resilience and aims for zero dividend decision at AGM

19 March 2020 - Kvaerner is monitoring the development of the covid-19 virus development with deep concern and full commitment to apply all necessary measures to protect the life and health of our workforce, business partners and the society around us. Simultaneously, the company is implementing precautions to minimise as much as possible any negative influence of the virus situation for ongoing projects and for future business opportunities. Kvaerner has a robust financial platform, and a very good foundation to handle the current global situation with the least possible disruption to

EQT sets hard cap for EQT IX at EUR 15 billion

EQT has today set the hard cap for investor commitments of EUR 15 billion for the EQT IX fund. A hard cap refers to an upper limit on the amount of investor commitments accepted as part of the fund. The actual fund size is dependent on the outcome of the fundraising process. As previously communicated, the target fund size for EQT IX is EUR 14.75 billion and the fund’s investment strategy and commercial terms are expected to be materially in line with the predecessor fund EQT VIII. Invitation to telephone conference call on Thursday March 19 at 11.30 CETEQT invites to a telephone

The European Medicines Agency confirms that Intervacc’s application for the granting of a Community marketing authorization for Strangvac is complete and correctly submitted

Stockholm March 18, 2020 - Intervacc AB (publ) announces that the European Medicines Agency, EMA,  has today confirmed that the company's application for the granting of a Community marketing authorization for Strangvac is complete and correctly submitted. The regulatory review process for the vaccine against equine strangles, a highly contagious infectious disease now can be initiated. Today, in accordance with the applicable timetable for the application process, EMA has confirmed that the application for the granting of a Community marketing authorization for Strangvac submitted by

Name Change to Enad Global 7

As of tomorrow, March 19, 2020, the current Toadman Interactive share will be traded under the new name Enad Global 7 (EG7). The change of name for the market-listed share will take effect as a result of the new company name having now been registered with the Swedish Companies Registration Office. At the Extra General Meeting on March 3, it was decided that Enad Global 7 AB should be the new name of former Toadman Interactive. The new name has now been registered with the Swedish Companies Registration Office, which is why the company's market-listed share also changes its name to Enad

Kesko Corporation issues a profit warning: Due to COVID-19 and global economic uncertainty, the company cancels its previous net sales guidance and changes its operating profit guidance

Kesko cancels the outlook statement regarding the net sales for continuing operations and changes the outlook statement regarding the comparable operating profit for continuing operations, both issued in connection with the Financial Statements release on 5 February 2020. Under the prevailing circumstances, the company estimates that the comparable operating profit for continuing operations in 2020 will amount to €400-450 million, thus falling somewhat short of the record comparable operating profit for 2019. The company does not issue a new guidance for net sales.“Due to the COVID-19

Practical instructions regarding Ahlstrom-Munksjö’s Annual General Meeting

AHLSTROM-MUNKSJÖ OYJ STOCK EXCHANGE RELEASE March 18, 2020 at 20:35 EET  In response to the coronavirus infection risk, Ahlstrom-Munksjö has decided to make certain changes to the practical arrangements of its Annual General Meeting at Finlandia hall, in Helsinki on March 25, 2020, at 13:00 EET.  At the same time as the Board recognizes the exceptional circumstances, it strives to maintain the corporate governance as smoothly as possible and to ensure the best interests of the company and its shareholders by organizing the Annual General Meeting according to the agreed time schedule.

Resolutions made at Axfood’s 2020 Annual General Meeting

The Annual General Meeting (AGM) re-elected all of the Company’s board members and elected Christian Luiga as a new director. The AGM resolved, among other things, to pay a dividend of SEK 7.25 per share and to implement an additional long-term incentive programme.The Annual General Meeting of Axfood Aktiebolag (publ) was held on Wednesday, 18 March 2020, in Stockholm.Adoption of the income statement and balance sheet, and the consolidated income statement and consolidated balance sheetThe AGM adopted the parent company and consolidated income statements and balance sheets for the 2019

New I-Tech customer launches Selektope®-containing products

Leading Norwegian paint-manufacturer Jotun has commercialized two new marine paint products containing I-Tech’s antifouling active agent Selektope®.     Jotun, the world’s largest manufacturer of marine paints, will use Selektope® in two antifouling products targeting customers within commercial shipping where increased protection against barnacle fouling is needed for idle ships during the outfitting period.  I-Tech and Jotun are yet to formalize an agreement that binds orders for the commercialization. Therefore, the company can not issue any statement regarding volumes and

Idogen publishes outcome in rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.  The Board of Directors of Idogen AB (”Idogen” or the ”Company”) today publishes the outcome in the new share issue with preferential rights for Idogen’s existing shareholders (the “Rights issue”) that was resolved upon by the Board of Directors on January 28, 2020 and approved by the Company’s Extraordinary General

SimCorp withdraws 2020 guidance due to outbreak of Covid-19 (Coronavirus)

Company Announcement no. 10/2020 SimCorp today announces that: · SimCorp’s performance for the first two months of the year has been in line with its budget and expectations · SimCorp remains in a strong financial position with a large part of the annual revenue being of a recurring nature, and as of today, signed revenue for full year 2020 is EUR 310m · SimCorp still plans to pay dividends as set out in the notice of the Annual General Meeting, subject to shareholder approval · SimCorp will continue the current EUR 10m phase of the share buy back program, but will not

There are no items matching the current filter
There are no more items matching the current filter
Back to top